Robert J. Gould
2019 - Fulcrum Therapeutics
In 2019, Robert J. Gould earned a total compensation of $3.9M as President and Chief Executive Officer at Fulcrum Therapeutics, a 356% increase compared to previous year.
Compensation breakdown
| Bonus | $300,000 |
|---|---|
| Option Awards | $3,111,158 |
| Salary | $478,195 |
| Total | $3,889,353 |
Gould received $3.1M in option awards, accounting for 80% of the total pay in 2019.
Gould also received $300K in bonus and $478.2K in salary.
Rankings
In 2019, Robert J. Gould's compensation ranked 3,081st out of 13,971 executives tracked by ExecPay. In other words, Gould earned more than 77.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,081 out of 13,971 | 78th |
Division Manufacturing | 1,113 out of 5,695 | 81st |
Major group Chemicals And Allied Products | 377 out of 2,194 | 83rd |
Industry group Drugs | 310 out of 1,880 | 84th |
Industry Pharmaceutical Preparations | 228 out of 1,392 | 84th |
Source: SEC filing on April 29, 2020.
Gould's colleagues
We found two more compensation records of executives who worked with Robert J. Gould at Fulcrum Therapeutics in 2019.